New drug for kidney transplant recipients effective in humans
February 16, 2010 by admin · Leave a Comment
Contact: Jennifer Beal
medicalnews@wiley.com
44-124-377-0633
Wiley-Blackwell Read more
New therapeutic approach identified for kidney disease associated with lupus
January 24, 2010 by admin · Leave a Comment
Contact: phyllis fisher
fisherp@hss.edu
212-606-1197
Hospital for Special Surgery
Investigators have identified a new disease mechanism and therapeutic approach for a type of advanced kidney disease that is a common cause of complications in patients with lupus. The study was led by investigators at Hospital for Special Surgery and appears in the January 25 online Early Edition of the Proceedings of the National Academy of Sciences.
Research at UCSB points to potential treatment for kidney disease
January 24, 2010 by admin · Leave a Comment
Contact: Gail Gallessich
805-893-7220
University of California - Santa Barbara
(Santa Barbara, Calif.) Research performed at UC Santa Barbara points to the drug rapamycin as a potential treatment for kidney disease. The study builds on past research and shows that studies performed on mice are more likely to translate to humans than previously thought. The results are published in the current online issue of the Journal of the American Society of Nephrology.
Abnormal blood calcium levels deadly for kidney disease patients
Contact: Shari Leventhal
sleventhal@asn-online.org
202-416-0658
American Society of Nephrology Read more
Gene for devastating kidney disease discovered
December 20, 2009 by admin · Leave a Comment
Contact: Keri Stedman
keri.stedman@childrens.harvard.edu
617-919-3110
Children’s Hospital Boston Read more
Controversial kidney transplant technique could provide lifeline for very ill patients
December 6, 2009 by admin · Leave a Comment
Contact: Annette Whibley
wizard.media@virgin.net
Wiley-Blackwell Read more
Stem cells offer new hope for kidney disease patients
October 15, 2009 by admin · Leave a Comment
For Alport syndrome, several cell-based therapies show promise
Several cell-based therapy approaches could provide new treatments for patients with Alport syndrome, reports an upcoming paper in the Journal of the American Society of Nephrology (JASN). “Our study opens up many considerations of how new therapies related to the use of stem cells can be devised for our kidney patients with chronic disease,” comments Raghu Kalluri, MD, PhD (Harvard Medical School, Boston, MA).
Weight loss found to be good for the kidneys
September 18, 2009 by admin · Leave a Comment
Diet, exercise and surgery may all prevent kidney disease progression
Losing weight may preserve kidney function in obese people with kidney disease, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that taking off the pounds could be an important step kidney disease patients can take to protect their health.
Study finds novel genetic risk factors for kidney disease
May 10, 2009 by admin · Leave a Comment
A team of researchers from the United States, the Netherlands and Iceland has identified three genes containing common mutations that are associated with altered kidney disease risk. One of the discovered genes, the UMOD gene, produces Tamm-Horsfall protein, the most common protein in the urine of healthy individuals. Although the Tamm-Horsfall protein has been known for almost 60 years, its functions are not well understood and its relationship to chronic kidney disease risk was not known previously. The findings are published in the May 10 issue of Nature Genetics.
Enzyme Replacement therapy slows kidney function decline
April 9, 2009 by admin · Leave a Comment
For men with Fabry disease, enzyme replacement therapy (ERT) with agalsidase alfa slows deterioration of kidney function, reports a study in the online edition of the Journal of the American Society of Nephrology (JASN). “The results provide further evidence that ERT with agalsidase alfa may slow the progression of kidney disease, provided that ERT is initiated early in the disease process,” comments Michael L. West, MD (Dalhousie University, Canada).
